Find News

Filter articles

Showing 3141 to 3150 of 3373 results

Idenix brings Gilead patent battle to Europe

France, Germany, UK17-03-2014Legal developments

Massachusetts-based Idenix Pharmaceuticals has filed patent infringement cases against Gilead Sciences and its European subsidiaries in France, Germany and the UK.

“Patent cliff” blamed for contraction in Irish economy


A contraction of 0.3 percent in Ireland’s economy last year has been linked to the expiry of several key pharmaceutical patents.

Vaccine maker KAEL-GemVax appoints CPA Global as IP specialist

South Korea13-03-2014

South Korean cancer vaccine maker KAEL-GemVax has appointed CPA Global as its IP management specialist.

Generics circle as Virginia court invalidates Celebrex patent

US13-03-2014Legal developments

The US District Court for the Eastern District of Virginia has invalidated one of Pfizer’s patents covering blockbuster arthritis drug Celebrex.

Myriad suffers setback in attempt to block Ambry BRCA test

US12-03-2014Legal developments

Genetic diagnostic company Myriad Genetics and other patent holders have been denied a motion for a preliminary injunction that would have kept rival company Ambry Genetics from selling its own test for BRCA gene mutations.

Novo Nordisk signs insulin deal with Caisson


Texas-based biopharmaceutical company Caisson Biotech has expanded its partnership with diabetes therapy maker Novo Nordisk by giving Novo exclusive rights to commercialise an insulin treatment that uses Caisson’s drug delivery technology.

Update to UPC rules clarifies “opt-out” scheme


The Unified Patent Court has clarified its opt-out scheme, making clear that when a European patent has been opted out of the scheme, its associated supplementary protection certificate will follow.

Life Sciences Law Forum: UPC: “So much more to be done”


While the political will exists for the introduction of the Unified Patent Court next year, much more still needs to be done, according to Adam Cooke, a partner in DLA Piper's IP and technology group.

Life Sciences Law Forum: disclosure of clinical data a key concern


A key concern for lawyers and in-house counsels practising in the pharmaceutical industry is the disclosure of clinical data, according to the co-chairs of DLA Piper's Global Life Sciences sector, Bonella Ramsay and John Dougherty.

Indian court dismisses Teva’s bid to block Copaxone generic


The Delhi High Court has dismissed Teva’s action to stop Hyderabad-based Natco Pharma from marketing a generic version of its blockbuster multiple sclerosis drug Copaxone (glatiramer acetate).

Showing 3141 to 3150 of 3373 results